Möröy T, Khandanpour C.
Editorial: New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies
Front Oncol. 2023 Aug 1;13:1256461. doi: 10.3389/fonc.2023.1256461.
Lacroix M, Beauchemin H, Khandanpour C, Möröy T.
The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma
Front Oncol. 2023 Mar 24;13:1148936. doi: 10.3389/fonc.2023.1148936.
Lacroix M, Beauchemin H, Möröy T.
DDX3: a relevant therapeutic target for lymphoma?
Expert Opin Ther Targets. 2022 Dec;26(12):1037-1040. doi: 10.1080/14728222.2022.2166830. Epub 2023 Jan 10.
Fraszczak J, Möröy T.
The transcription factors GFI1 and GFI1B as modulators of the innate and acquired immune response
Adv Immunol. 2021;149:35-94. doi: 10.1016/bs.ai.2021.03.003.
Ross J, Miron CE, Plescia J, Laplante P, McBride K, Moitessier N, Möröy T.
Targeting MYC: From understanding its biology to drug discovery
Eur J Med Chem. 2021 Mar 5;213:113137. doi: 10.1016/j.ejmech.2020.113137.
Arman K, Möröy T.
Crosstalk between MYC and lncRNAs in hematological malignancies
Front Oncol. 2020 Oct 8;10:579940. doi: 10.3389/fonc.2020.579940.
Beauchemin H, Möröy T.
Multifaceted actions of GFI1 and GFI1B in hematopoietic stem cell self-renewal and lineage commitment
Front Genet. 2020 Oct 26;11:591099. doi: 10.3389/fgene.2020.591099.
Möröy T, Khandanpour C.
Role of GFI1 in epigenetic regulation of MDS and AML pathogenesis: Mechanisms and therapeutic implications
Front Oncol. 2019 Aug 27;9:824. doi: 10.3389/fonc.2019.00824.
Fraszczak J, Möröy T.
The role of the transcriptional repressor growth factor independent 1 in the formation of myeloid cells
Curr Opin Hematol. 2017 Jan;24(1):32-37. doi: 10.1097/MOH.0000000000000295.
Möröy T, Vassen L, Wilkes B, Khandanpour C.
From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation
Blood. 2015 Dec 10;126(24):2561-9. doi: 10.1182/blood-2015-06-655043.
Khandanpour C and Möröy T.
Gfi1 as a regulator of p53 and a therapeutic target for ALL
Oncotarget, 2013, Mar;4(3):374-375. doi: 10.18632/oncotarget.933.
Möröy T, Saba I, Kosan C.
The role of the transcription factor Miz-1 in lymphocyte development and lymphomagenesis-Binding Myc makes the difference
Semin Immunol. 2011 Oct;23(5):379-387. doi: 10.1016/j.smim.2011.09.001.
Möröy T, Khandanpour C.
Growth factor independence 1 (Gfi1) as a regulator of lymphocyte development and activation
Semin Immunol. 2011 Oct;23(5):368-378. doi: 10.1016/j.smim.2011.08.006.
Möröy T, Khandanpour C .
GFI1 (growth factor independent 1 transcription repressor)
Atlas Genet Cytogenet Oncol Haematol. 2011; 15(10):821-827.
Möröy T, Vassen L.
GFI1B (growth factor independent 1B transcription repressor)
Atlas Genet Cytogenet Oncol Haematol. 2011; 15(3):266-269.
Möröy T, Heyd F.
The impact of alternative splicing in vivo: mouse models show the way
RNA. 2007 Aug;13(8):1155-1171. doi: 10.1261/rna.554607.
Bachmann M, Möröy T.
The serine/threonine kinase Pim-1
Int J Biochem Cell Biol. 2005 Apr;37(4):726-30. doi: 10.1016/j.biocel.2004.11.005.
Möröy T.
The zinc finger transcription factor Growth factor independence 1 (Gfi1)
Int J Biochem Cell Biol. 2005 Mar;37(3):541-6. doi: 10.1016/j.biocel.2004.08.011.
Möröy T, Geisen C.
Cyclin E
Int J Biochem Cell Biol. 2004 Aug;36(8):1424-39. doi: 10.1016/j.biocel.2003.12.005.
Möröy T, Karsunky H.
Regulation of pre-T-cell development
Cell Mol Life Sci. 2000 Jun;57(6):957-75. doi: 10.1007/PL00000737.